A multi-center population-based case-control study of ovarian cancer in African-American women: The African American Cancer Epidemiology Study (AACES)

BMC Cancer

Volumn 14, Issue 1, 2014, Pages

  Schildkraut, Joellen M ^a   Alberg, Anthony J ^b   Bandera, Elisa V ^c   Barnholtz Sloan, Jill ^d   Bondy, Melissa ^e   Cote, Michelle L ^f   Funkhouser, Ellen ^g   Peters, Edward ^h   Schwartz, Ann G ^f   Terry, Paul ⁱ   Wallace, Kristin ^b   Akushevich, Lucy ^a   Wang, Frances ^a   Crankshaw, Sydnee ^a   Moorman, Patricia G ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

^d CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e BAYLOR COLLEGE OF MEDICINE   (United States)

^f WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g University of Alabama at Birmingham   (United States)

^h Department of Pathology   (United States)

ⁱ UNIVERSITY OF TENNESSEE   (United States)

Author keywords

African American; Case control study; Epidemiology; Ovarian cancer

Indexed keywords

ADULT; AFRICAN AMERICAN; AGE DISTRIBUTION; AGED; ARTICLE; BODY HEIGHT; BODY MASS; BODY WEIGHT; CANCER SCREENING; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA DETERMINATION; FEMALE; FOLLOW UP; FOOD FREQUENCY QUESTIONNAIRE; GEOGRAPHIC DISTRIBUTION; HIP CIRCUMFERENCE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MENSTRUATION; MIDDLE AGED; OVARY CANCER; POPULATION BASED CASE CONTROL STUDY; RISK ASSESSMENT; RISK FACTOR; SOCIAL STATUS; WAIST CIRCUMFERENCE; YOUNG ADULT; CANCER GRADING; CANCER STAGING; CASE CONTROL STUDY; CLINICAL TRIAL; HEALTH SURVEY; MULTICENTER STUDY; OVARIAN NEOPLASMS; QUESTIONNAIRE; RISK; UNITED STATES;

ADULT; AFRICAN AMERICANS; AGED; CASE-CONTROL STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; ODDS RATIO; OVARIAN NEOPLASMS; POPULATION SURVEILLANCE; QUESTIONNAIRES; RISK FACTORS; UNITED STATES; YOUNG ADULT;

EID: 84910071620     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-14-688     Document Type: Article

References (21)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2012, 62(1):10-29. 10.3322/caac.20138, 22237781.
2. DeSantis C, Naishadham D, Jemal A. Cancer statistics for African Americans, 2013. CA Cancer J Clin 2013, 63(3):151-166. 10.3322/caac.21173, 23386565.
3. Chornokur G, Amankwah EK, Schildkraut JM, Phelan CM. Global ovarian cancer health disparities. Gynecol Oncol 2013, 129(1):258-264. 10.1016/j.ygyno.2012.12.016, 3608795, 23266352.
4. SEER Cancer Statistics Review, 1975-2008. 2011, Bethesda, MD: National Cancer Institute, Howlader N, Noone AM, Krapcho M, Neyman N, Aminou R, Waldron W, Altekruse SF, Kosary CL, Ruhl J, Tatalovich Z, Mariotto A, Eisner MP, Lewis DR, Chen HS, Feuer EJ, Cronin KA, Edwards BK, http://seer.cancer.gov/archive/csr/1975_2008/; based on November 2010 SEER data submission, posted to the SEER web site, 2011.
5. Barnholtz-Sloan JS, Tainsky MA, Abrams J, Severson RK, Qureshi F, Jacques SM, Levin N, Schwartz AG. Ethnic differences in survival among women with ovarian carcinoma. Cancer 2002, 94(6):1886-1893. 10.1002/cncr.10415, 11920552.
6. Du XL, Sun CC, Milam MR, Bodurka DC, Fang S. Ethnic differences in socioeconomic status, diagnosis, treatment, and survival among older women with epithelial ovarian cancer. Int J Gynecol Cancer 2008, 18(4):660-669. 10.1111/j.1525-1438.2007.01081.x, 17892451.
7. Farley JH, Tian C, Rose GS, Brown CL, Birrer M, Maxwell GL. Race does not impact outcome for advanced ovarian cancer patients treated with cisplatin/paclitaxel: an analysis of Gynecologic Oncology Group trials. Cancer 2009, 115(18):4210-4217. 10.1002/cncr.24482, 19536873.
8. Terplan M, Schluterman N, McNamara EJ, Tracy JK, Temkin SM. Have racial disparities in ovarian cancer increased over time? An analysis of SEER data. Gynecol Oncol 2012, 125(1):19-24. 10.1016/j.ygyno.2011.11.025, 22108636.
9. Howell EA, Egorova N, Hayes MP, Wisnivesky J, Franco R, Bickell N. Racial disparities in the treatment of advanced epithelial ovarian cancer. Obstet Gynecol 2013, 122(5):1025-1032. 10.1097/AOG.0b013e3182a92011, 24104782.
10. Schildkraut JM, Iversen ES, Akushevich L, Whitaker R, Bentley RC, Berchuck A, Marks JR. Molecular Signatures of Epithelial Ovarian Cancer: Analysis of Associations with Tumor Characteristics and Epidemiologic Risk Factors. Cancer Epidemiol Biomarkers Prev 2013, 22(10):1709-1721. 10.1158/1055-9965.EPI-13-0192, 23917454.
11. John EM, Whittemore AS, Harris R, Itnyre J. Characteristics relating to ovarian cancer risk: collaborative analysis of seven U.S. case-control studies. Epithelial ovarian cancer in black women. Collaborative Ovarian Cancer Group. J Natl Cancer Inst 1993, 85(2):142-147. 10.1093/jnci/85.2.142, 8418303.
12. Ness RB, Grisso JA, Cottreau C, Klapper J, Vergona R, Wheeler JE, Morgan M, Schlesselman JJ. Factors related to inflammation of the ovarian epithelium and risk of ovarian cancer. Epidemiology 2000, 11(2):111-117. 10.1097/00001648-200003000-00006, 11021606.
13. Moorman PG, Palmieri RT, Akushevich L, Berchuck A, Schildkraut JM. Ovarian cancer risk factors in African-American and white women. Am J Epidemiol 2009, 170(5):598-606. 10.1093/aje/kwp176, 2732987, 19605513.
14. Schildkraut JM, Murphy SK, Palmieri RT, Iversen E, Moorman PG, Huang Z, Halabi S, Calingaert B, Gusberg A, Marks J, Berchuck A. Trinucleotide repeat polymorphisms in the androgen receptor gene and risk of ovarian cancer. Cancer Epidemiol Biomarkers Prev 2007, 16(3):473-480. 10.1158/1055-9965.EPI-06-0868, 17372242.
15. Schildkraut JM, Goode EL, Clyde MA, Iversen ES, Moorman PG, Berchuck A, Marks JR, Lissowska J, Brinton L, Peplonska B, Cunningham JM, Vierkant RA, Rider DN, Chenevix-Trench G, Webb PM, Beesley J, Chen X, Phelan C, Sutphen R, Sellers TA, Pearce L, Wu AH, Van Den Berg D, Conti D, Elund CK, Anderson R, Goodman MT, Lurie G, Carney ME, Thompson PJ, et al. Single nucleotide polymorphisms in the TP53 region and susceptibility to invasive epithelial ovarian cancer. Cancer Res 2009, 69(6):2349-2357. 10.1158/0008-5472.CAN-08-2902, 2666150, 19276375.
16. Grant DJ, Hoyo C, Akushevich L, Iversen ES, Whitaker R, Marks J, Berchuck A, Schildkraut JM. Vitamin D receptor (VDR) polymorphisms and risk of ovarian cancer in Caucasian and African American women. Gynecol Oncol 2013, 129(1):173-178. 10.1016/j.ygyno.2012.12.027, 23262379.
17. Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)-a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 2009, 42(2):377-381. 10.1016/j.jbi.2008.08.010, 2700030, 18929686.
18. Morton LM, Cahill J, Hartge P. Reporting participation in epidemiologic studies: a survey of practice. Am J Epidemiol 2006, 163(3):197-203.
19. Galea S, Tracy M. Participation rates in epidemiologic studies. Ann Epidemiol 2007, 17(9):643-653. 10.1016/j.annepidem.2007.03.013, 17553702.
20. Sieh W, Salvador S, McGuire V, Weber RP, Terry KL, Rossing MA, Risch H, Wu AH, Webb PM, Moysich K, Doherty JA, Felberg A, Miller D, Jordan SJ, Goodman MT, Lurie G, Chang-Claude J, Rudolph A, Kjaer SK, Jensen A, Hogdall E, Bandera EV, Olson SH, King MG, Rodriguez-Rodriguez L, Kiemeney LA, Marees T, Massuger LF, van Altena AM, Ness RB, et al. Tubal ligation and risk of ovarian cancer subtypes: a pooled analysis of case-control studies. Int J Epidemiol 2013, 42(2):579-589. 10.1093/ije/dyt042, 3619957, 23569193.
21. Schildkraut JM, Thompson WD. Relationship of epithelial ovarian cancer to other malignancies within families. Genet Epidemiol 1988, 5(5):355-367. 10.1002/gepi.1370050506, 3215509.